Sign in
BioinformaticsFrontiers in Bioinformatics
Peer-reviewed journal article

An assessment of bioinformatics tools for the detection of human endogenous retroviral insertions in short-read genome sequencing data

Harry BowlesiD, Renata KabiljoiD, Ashley JonesiD, Ahmad Al KhleifatiD, John Peter QuinniD, Richard DobsoniD, Chad M. SwansoniD, Ammar Al‐ChalabiiD, Alfredo IacoangeliiD

Abstract

There is a growing interest in the study of human endogenous retroviruses (HERVs) given the substantial body of evidence that implicates them in many human diseases. Although their genomic characterization presents numerous technical challenges, next-generation sequencing (NGS) has shown potential to detect HERV insertions and their polymorphisms in humans, and a number of computational tools to detect them in short-read NGS data exist. In order to design optimal analysis pipelines, an independent evaluation of the currently available tools is required. We evaluated the performance of a set of such tools using a variety of experimental designs and types of NGS datasets. These included 50 human short read whole-genome sequencing samples, matching long and short read NGS data, and simulated short-read NGS data. Our results highlight the performance variability of the tools across the datasets and suggest that different tools might be suitable for different study designs. Using multiple tools and a consensus approach is advisable if computationally feasible and wet-lab validation via PCR is advisable where biological samples are available.

PDFDOI

02 /Specification & Classification

Click any tag to browse matching papers

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISKabiljo '22Chen '19Patterson '26Thomas '18Seymen '25Delage '20
72% semantic matchGenomics
Renata Kabiljo, Harry Bowles, Heather Marriott+7 more·bioRxiv·Apr 8, 2022